Injectables marketing agency for Dallas aesthetic practices — neuromodulators, fillers, biostimulators, threads, PRP and Kybella, all inside a TX Med Board 165.5 and FDA-safe envelope
Ichelon Consulting US runs the full injectables marketing motion for Dallas aesthetic practices — from single-injector Highland Park suites through PE-backed DFW platforms. Neuromodulators (Botox, Dysport, Xeomin, Daxxify, Jeuveau, Letybo), the full HA filler shelf (Juvederm, Restylane, RHA, Belotero), biostimulators (Sculptra, hyperdilute Radiesse), PMMA (Bellafill), PDO and PLLA threads (MINT, NovaThreads, Silhouette InstaLift), PRP and PRF (face + hair), and Kybella all run inside a single Texas Medical Board Rule 165.5-safe, FDA 21 CFR §202.1-compliant, HIPAA-scoped, TCPA-safe envelope. Dallas HQ, DFW-native delivery, healthcare-only team.
- Injectables is the operating category — not a single product. Dallas practices that price and market Botox, filler, Sculptra, threads, PRP and Kybella as one connected arc compound LTV three-to-five times harder than practices that treat each product as a standalone funnel.
- The compliance envelope is four rulebooks deep: Texas Medical Board Rule 165.5 (before/after, testimonials), FDA 21 CFR §202.1 (on-label promotion for every FDA-cleared injectable), Meta Personal Attributes (STRICT on aesthetic creatives), and FTC 16 CFR §255 (endorsements + testimonials + material connection).
- Highland Park and Preston Hollow carry the highest CPCs in Texas injectable auctions. Uptown and Park Cities carry the young-professional and cross-sell buyer. DFW suburbs (Frisco, Plano, McKinney) carry family-aesthetic and post-baby demand at more accessible CPCs.
- Retainers $2,500 to $8,000/month, custom-scoped. Media pass-through separate. Angryturtle GBP OS runs in parallel for multi-location injectable platforms.
- Dallas, Texas LLC
- 10-person US client team · Central Time (CST)
- 25+ US healthcare clients
- BAA signed with every client
- HIPAA compliance training across client and delivery teams
- Contracts and invoices in USD
-
Primary Care · North Dallas, TXCase study →
-
MedSpa · North Dallas, TX
-
Skin Care · Beverly Hills, CA
-
Dental · Christiansburg, VACase study →
-
Pediatrics · Blacksburg, VACase study →
-
Pediatric Dentistry · Blacksburg, VACase study →
-
Dental · Roanoke, VACase study →
-
Functional Medicine · Telehealth · USACase study →
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Why Dallas injectable practices work with Ichelon Consulting US
Dallas is where Ichelon Consulting US sits. Our US office runs Central Time hours from a Matador Drive address inside the DFW aesthetic corridor, which means the scoping calls, the creative reviews, the Rule 165.5 back-catalog audits, and the injector on-camera capture sessions all happen in-market. The five factors below concentrate why Dallas injectable practices in Highland Park, Preston Hollow, Uptown, Park Cities and the northern DFW corridor choose us over generic aesthetic or generalist digital agencies.
First, we scope every injectable product on its own compliance surface — a Sculptra creative gets a different pre-flight than a Botox creative, which gets a different pre-flight than a PDO thread creative. Second, we treat injectables as one connected LTV motion instead of six separate service lines, which is how the Dallas buyer actually behaves. Third, Rule 165.5 and Rule 165.1 are pre-flight passes on every headline, subhead, ad variation, organic caption, and GBP post — not a legal review that happens after publication. Fourth, we ship the Dallas market from the Dallas market, not from a coast that has no context for Highland Park CPC pressure. Fifth, we have never named a competitor Dallas clinic in a marketing asset and we never will — the injectable community in Dallas is small enough that naming rivals is a reputational cost the clinic pays for years.
The engagement pattern most Dallas injectable practices settle into is a three-to-six-month build-out — full site audit, injectables catalog restructure, GBP density lift, membership funnel scope — then a steady-state monthly retainer with quarterly compliance re-audits. Retainers scale with location count and product mix, not with practice hype.
Why Dallas is the single most competitive injectables market in Texas
Dallas concentrates more per-capita injectable spend than any other Texas metro, and the auction reflects it. The Highland Park–Preston Hollow–University Park–Park Cities corridor carries the highest cost-per-click on branded and non-branded injectable intent in the state — not just for Botox and Dysport, but for Sculptra, RHA, PDO threads, and PRP hair. A clinic that ranks on brand recognition alone in this corridor is now competing with three or four new injectable-first entrants inside a two-mile radius that were not open eighteen months ago.
Five structural forces make Dallas injectable economics distinct. First, the recurring-revenue base. Dallas injectable buyers in the affluent submarkets treat Botox as a maintenance ritual, filler as a twice-a-year refresh, and Sculptra as a three-visit series over eight-to-twelve months. That means acquisition CAC amortizes across an eighteen-to-thirty-six-month window that includes at least four distinct product touches, not a single-visit ROAS.
Second, the inbound-migration cycle. Dallas has absorbed a decade of relocation from Southern California, the New York metro, and Chicago's North Shore. Those transplants arrive with a fully-formed sense of what their injectable home should look like — bedside manner, product breadth, membership pricing, Alle enrollment, before/after visibility — and they replace their prior provider inside eight to twelve weeks post-move. That is the highest-value acquisition window in the Dallas injectables market.
Third, the male buyer emergence. Dallas is one of the fastest-growing US metros for male injectables — jawline definition through masseter Botox and RHA 4, chin projection with Voluma, Kybella submental sculpting, "Brotox" and Nefertiti neck-band applications. The auction on those keywords is far softer than the general injectables auction because most Dallas clinics still write creative as if the buyer is a forty-year-old woman.
Fourth, the GLP-1 crossover. Semaglutide and tirzepatide prescribing across Dallas creates a secondary aesthetic demand curve — post-weight-loss "Ozempic face" volume replacement (Voluma, Sculptra, hyperdilute Radiesse), skin-tightening threads, and PRP for scalp changes — that plays directly into the multi-product injector's monthly revenue.
Fifth, the preventative-injectables trend among the twenty-eight-to-thirty-four cohort. Baby Botox, Botox-cocktail treatments (small units + biotin or vitamin infusion in some practices), lip-flip aesthetics, and micro-filler are all growing categories with buyers who convert to a fifteen-year LTV curve if the first visit is scoped correctly.
Texas Medical Board Rule 165.5 — how it changes every Dallas injectable creative
Rule 165.5 of the Texas Administrative Code (22 TAC §165.5) governs how a Texas-licensed physician — including the medical director of an injectables clinic — uses patient testimonials and before/after photography in advertising. Chapter 200 of the Board's Rules on physician-owned medical spas layers additional constraint. Enforcement in Dallas has been steady since 2023, and the fine schedule now scales with campaign impressions. A Highland Park clinic running a six-figure Meta budget on a non-compliant Sculptra or filler before/after Reel is not looking at a warning letter; it is looking at a corrective-advertising order plus disgorgement.
What Rule 165.5 requires on injectable before/after content
- Signed, dated patient consent for every face-visible injectable before/after image or Reel — Botox, filler, Sculptra, threads, PRP, Kybella all trigger the same consent requirement, with the specific use disclosed (Instagram, TikTok, Meta Ads, GBP, website gallery, YouTube).
- "Results not typical" or equivalent disclosure positioned in the same field of view as the image — not tucked into a caption below the fold. Filler and thread transformations get read as more dramatic than neuromodulators, so disclosure has to be tighter.
- No filter, no post-production smoothing, no lighting change between the "before" and "after" frame. Same angle, same distance, same lighting rig. This matters especially for Sculptra and hyperdilute Radiesse content where the change is a texture and quality change, not a volume change.
- Time-stamp visible or logged — three-week, three-month, six-month, and twelve-month follow-ups labeled distinctly (Sculptra results at week eight are visually different from Sculptra results at month five, and the buyer needs to know which one they are seeing).
- No compensated testimonial without disclosure of the compensation. That includes complimentary treatments in exchange for content — the FTC 16 CFR §255 endorsement rule and TX Rule 165.5 both bite.
What Rule 165.1 layers on top for injectables
Rule 165.1 governs false, deceptive, and misleading communication. Practically, it means the Dallas injectables clinic cannot use "best injector in Dallas," "leading filler clinic," "top-rated," "number one Sculptra provider," "the most trusted PRP clinic," or any implied guarantee of outcome. It also means every clinical claim — "instant lift with threads," "permanent filler results," "biostimulator regenerates collagen" — has to be defensible against the medical director's standard of care. Ichelon Consulting US's Rule 165.1 filter runs on every headline, subhead, ad copy variation, and organic caption before publication.
The pre-flight audit every Dallas injectables engagement starts with
First two weeks of every engagement, we run a Rule 165.5 back-catalog audit across the entire injectables portfolio. That means the practice's website gallery, every Instagram post with a face, every TikTok Reel, every GBP photo, every RealSelf case story, every retargeting creative, and every influencer collaboration receives a consent-trail check. Assets without consent get pulled from rotation until re-consent is documented. Assets with consent but weak disclosure language get re-cut. Thread and filler content gets audited more aggressively than Botox content because the visible transformation is larger.
FDA 21 CFR §202.1 — on-label promotion for every injectable product
Every FDA-approved injectable used in a Dallas practice has a specific on-label indication. FDA 21 CFR §202.1 and the FDA's guidance on prescription drug advertising prohibit promotional communication for an unapproved use. That constraint sits on the manufacturer directly. For a Dallas clinic, the constraint is looser — physicians can prescribe off-label — but the marketing surface is where FDA, the Texas Medical Board, and Meta's ad policy converge on liability. A clinic that runs "Sculptra for booty lift" as a Meta ad headline, or "Botox for TMJ pain" as a landing-page H1, is making a promotional claim about an unapproved use of an FDA-regulated prescription product. That copy has FDA exposure, TX Rule 165.1 exposure, and Meta ad-policy exposure all at once.
On-label FDA indications, quick reference
- Neuromodulators (Botox, Dysport, Xeomin, Daxxify, Jeuveau, Letybo): glabellar lines are on-label for all six. Lateral canthal (crow's feet) and forehead lines are on-label for most. Chronic migraine, hyperhidrosis, cervical dystonia, and overactive bladder are on-label for Botox only. Masseter, TMJ, "lip flip," Nefertiti neck-band, and platysma-band applications are off-label across the board.
- HA fillers (Juvederm Voluma / Vollure / Volbella / Ultra, Restylane Lyft / Refyne / Defyne / Kysse / Silk, RHA 2 / 3 / 4, Belotero): each SKU has a specific on-label indication (mid-face volume, perioral rhytids, lip augmentation, dynamic wrinkles). Off-label injection sites — temples, chin projection, jawline definition, non-surgical rhinoplasty — are described as visit outcomes, not FDA indications.
- Biostimulators (Sculptra, Radiesse): Sculptra is on-label for shallow-to-deep facial wrinkles and facial lipoatrophy. Radiesse is on-label for moderate-to-severe facial wrinkles and hand rejuvenation. Hyperdilute-Radiesse skin-quality application and Sculptra full-face collagen protocols are off-label uses handled at the consult.
- Bellafill (PMMA): on-label for nasolabial folds and acne scars. Off-label uses are consult-only.
- PDO / PLLA threads (MINT, NovaThreads, Silhouette InstaLift): FDA 510(k)-cleared for facial soft-tissue approximation. "Non-surgical facelift" language is a Rule 165.1 problem — we frame threads as a lift-and-support technique with realistic expectations.
- PRP / PRF: autologous — regulated as a blood product under 21 CFR 1271. FDA has not approved PRP for any aesthetic indication. Marketing describes the technique and the visit, not an FDA endorsement.
- Kybella (deoxycholic acid): on-label for submental fat. Off-label body application (jowls, bra fat) is consult-only.
The monthly delivery stack for a Dallas injectables clinic
Six layers, weighted per practice. A single-injector Preston Hollow suite weights heavy on Meta Ads and Instagram; a three-location injectable platform weights heavy on GBP density, per-location P&L attribution, and multi-product cross-sell orchestration. Everything below runs inside the Rule 165.5 + FDA 21 CFR §202.1 + HIPAA + TCPA envelope.
SEO — injectable-product intent clusters
Topic map organized by product family (neuromodulators, HA fillers, biostimulators, threads, PRP, Kybella), by concern (mid-face volume, jawline definition, nasolabial folds, tear troughs, submental fullness), and by neighborhood (Highland Park, Preston Hollow, Uptown, Park Cities). Product SKUs get their own hub pages where SEO intent exists.
Paid — Meta Advantage+ + Google + LSA
Meta Advantage+ carries most injectable cosmetic intent — visual creative wins the auction. Google Ads on branded plus high-intent non-branded ("Sculptra Highland Park," "PDO threads Preston Hollow," "filler injector Uptown"). Local Service Ads where the clinic qualifies. Every creative pre-cleared for Meta Personal Attributes policy.
Instagram + TikTok injector-brand
Injector-led Reels and TikTok — the buyer wants to see the hand holding the syringe and the cannula. Rule 165.5-safe before/after workflow for every product. FTC-disclosure schedule on every creator collaboration. Educational-first framing on injectable science; results-with-disclosure on transformation content.
GBP density per location
Angryturtle-run Google Business Profile for every location. Post cadence, review response with Rule 165.5-safe language, Q&A seeding on "injector near me" queries, service catalog depth (per-product pricing where the clinic allows), photo hygiene. Per-location review alerting on any negative review requiring medical-director response.
Membership + cross-sell orchestration
Injectables membership pricing (monthly units banked, filler credits, quarterly biostimulator sessions) is the strongest LTV lever for a Dallas practice. We scope enrollment landing pages, Alle and Aspire rewards integration, retention email + SMS sequences, and the visit-cadence trigger that converts a Botox member to a filler or Sculptra patient.
Reporting tied to booked injectables + ascension
Monthly reporting that ties ad spend to booked injectables visits, per-product unit revenue, and ascension revenue (filler after Botox, biostimulator after filler, thread after biostimulator) visible in attribution where the CRM supports it. Blended LTV against acquisition cost — not cost per lead alone.
Meta Personal Attributes policy — the single most common injectable ad rejection in Dallas
Meta's Personal Attributes ad policy prohibits creatives that imply the viewer has a specific personal attribute — age, appearance, medical condition, financial status. Injectable ad copy fails this test more than any other vertical on the platform. "Erase your wrinkles," "look ten years younger," "hide your marionette lines," "get rid of your undereye hollows," "fix your jowls" — every one of those triggers the policy. A Dallas practice that runs a Meta campaign at Highland Park CPC rates and gets a swath of ads paused for Personal Attributes has burned through the auction learning phase for nothing.
How we rewrite injectable creative for the policy
- First-person, aspirational voice: "I wanted my jawline to feel like mine again," "how I book my quarterly filler refresh," "why Preston Hollow injectors trust Sculptra for the long game."
- Category framing, not viewer framing: "How Sculptra rebuilds collagen over three visits," "what a lip filler consult in Uptown actually looks like" — describing the treatment, not the viewer.
- Injector-led education: the licensed injector on-camera explaining the product, the units or syringes, the follow-up cadence. Personal Attributes rejections drop to near zero on injector-led content across all injectable products.
- Membership and pricing transparency: "Members book maintenance at [$X]/unit" — the ad is about the offer, not about the viewer's face.
The upside of this rewrite is not just Meta approval — the click-through rate on first-person and injector-led injectable creative in Dallas runs 40 to 70% higher than the classic "wrinkles-erased" formula, because it matches how the buyer actually thinks about the visit.
Dallas injectables CPQL benchmarks — by product and neighborhood
Cost per qualified lead for a Dallas injectables consultation varies with the injectable product, submarket auction pressure, creative maturity, and how tightly the landing experience is scoped for cash-pay conversion. Ranges below are mature-campaign observations across Ichelon Consulting US injectable engagements. First-quarter campaigns typically run 30 to 60% higher while creative iterates and audiences stabilize.
| Injectable product / campaign | Highland Park / Preston Hollow | Uptown / Park Cities | DFW suburbs (Frisco, Plano, McKinney) |
|---|---|---|---|
| Neuromodulator consult (Botox, Dysport, Daxxify) | $50–$110 | $45–$95 | $35–$75 |
| HA filler consult (Juvederm, Restylane, RHA) | $70–$150 | $60–$125 | $50–$100 |
| Biostimulator consult (Sculptra, Radiesse) | $90–$180 | $75–$155 | $60–$125 |
| PDO / PLLA thread consult | $85–$170 | $70–$145 | $55–$115 |
| PRP facial + PRP hair combined | $65–$140 | $55–$115 | $45–$95 |
| Kybella submental consult | $60–$130 | $50–$110 | $40–$85 |
| Injectables membership enrollment | $75–$160 | $65–$135 | $55–$115 |
CPQL is not the whole picture. A $150 Highland Park filler lead that books a two-syringe Voluma visit at $1,600 and enrolls in a $200/month injectables membership is more valuable than a $50 DFW-suburb neuromodulator lead that books a single 20-unit visit and never returns. We track blended LTV against acquisition cost inside the monthly reporting, weighted by product-mix ascension probability.
What we found when we studied 555 US med spas on Google
Patients praise the care almost without exception. The one area where complaints outnumber praise is booking and communication, and that is where most med spas can win.
City figures from 34 med spas; smaller samples swing more, so read them as typical rather than exact.
Full study · 555 US med spas across 20 metros · roughly ±4% nationally · review velocity and themes from a 115-spa subsample · verified against raw data.
The full Dallas injectables catalog we build marketing around
A Dallas injectables clinic that sells six product families under one roof needs a marketing engine that treats each product as its own SEO hub, its own paid creative surface, its own consult conversation, and its own ascension trigger. The catalog below is the working shelf we build product-page depth, ad copy, and consult intake around.
Neuromodulators
Botox (onabotulinumtoxinA — Allergan / AbbVie), Dysport (abobotulinumtoxinA — Galderma), Xeomin (incobotulinumtoxinA — Merz), Daxxify (daxibotulinumtoxinA-lanm — Revance), Jeuveau (prabotulinumtoxinA-xvfs — Evolus), and Letybo (letibotulinumtoxinA-wlbg — Hugel). Each product carries a distinct duration profile, onset window, and price point that shows up in the consult conversation. Marketing describes the product family and each SKU's approved indication; the injector picks the product for the patient in the consult.
Hyaluronic acid (HA) fillers
Juvederm Voluma XC (mid-face volume), Vollure XC (moderate wrinkles), Volbella XC (lip augmentation, undereye), Ultra XC (lip volume), and Ultra Plus XC (deeper folds) — all Allergan / AbbVie. Restylane Lyft (mid-face volume), Refyne (dynamic wrinkles), Defyne (deeper wrinkles), Kysse (lip augmentation), and Silk (fine lines) — all Galderma. RHA 2, 3, and 4 (dynamic wrinkles, Revance-distributed). Belotero Balance (superficial lines, Merz). Product-specific landing pages give the Dallas buyer the depth they research on before booking.
Biostimulators and collagen builders
Sculptra (poly-L-lactic acid, Galderma) — three-session facial protocol for gradual collagen rebuild. Radiesse (calcium hydroxylapatite, Merz) — mid-to-deep folds plus hyperdilute skin-quality applications. Bellafill (PMMA microspheres, Suneva) — long-duration filler for nasolabial folds and acne scars. Biostimulator marketing is a longer-timeline story than filler or neuromodulator marketing, and the creative has to set expectations across a three-to-six-month buyer journey.
PDO and PLLA threads
MINT PDO (mono, cog, and screw configurations for lift and support), NovaThreads (Sunset Chemical, mono and barbed), and Silhouette InstaLift (PLLA-PLGA suture cones, Sinclair). Thread marketing has to navigate Rule 165.1 carefully — "non-surgical facelift" language fails superiority testing, and buyer expectations run high on threads. Injector-led education content converts better than transformation before/after in the thread category.
PRP and PRF
Autologous platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) for facial rejuvenation (microneedling combination) and hair restoration (androgenetic alopecia scalp injections). PRP is not FDA-approved for aesthetic indications — marketing describes technique and visit, never an FDA endorsement. PRP facial and PRP hair share buyers in Dallas — a coordinated funnel with two landing pages and shared retargeting audiences is the correct architecture.
Kybella and cocktail treatments
Kybella (deoxycholic acid, Allergan) for submental fat — on-label. Botox-cocktail treatments (small units of neuromodulator combined with skin boosters, biotin infusions, or NCTF-135 depending on practice) are described as visit protocols, not FDA-approved combinations. Off-label body Kybella (jowls, bra fat) stays inside the consult.
The first injectable visit is the highest-intent moment for cross-sell
Every marketing conversation about a single injectable eventually becomes a marketing conversation about the next injectable in the arc. The Highland Park buyer who books a Botox consult is not only asking about frown lines — she is assessing whether this clinic will be her injectable home for the next three-to-five years across Botox, filler, Sculptra, threads, PRP, and eventual maintenance. The clinic that treats the consult as a single-service transaction gets the visit; the clinic that treats it as the entry-point to a full injectable arc captures the LTV.
Pre-visit intake — set the ascension up before the injector walks in
A well-structured pre-visit intake asks about neuromodulator history, prior injector experience, and glabellar / crow's feet concerns, but also lower-face concerns (lip proportion, chin projection, jawline definition, marionette lines), texture concerns (pore size, laxity), volume concerns (mid-face, temples, tear troughs), scalp concerns for PRP candidates, and post-weight-loss changes if the buyer is on GLP-1s. That intake tells the injector where the ascension conversation goes and which product families to introduce in what order.
Post-visit sequence — the seven-to-twenty-eight-day window
Botox results take seven to fourteen days to peak. Filler is immediate but settles over two weeks. Sculptra and thread results build across months. Day 14 is when the neuromodulator buyer decides whether this clinic is her home. A post-visit email + SMS sequence that lands on day 3 (check-in), day 10 (results check + filler consult offer), day 21 (skincare regimen recommendation), and day 28 (biostimulator or membership enrollment offer) is worth more revenue-per-visit than any acquisition channel by itself. Every touchpoint is TCPA-compliant on SMS opt-in and CAN-SPAM-compliant on email.
Provider talking-points sheet
Marketing produces the provider-facing talking-point sheet — the two-page reference that tells the injector how the ad campaign is framing the visit, what expectations the buyer walked in with, and how to bridge the neuromodulator consult to a filler assessment, a Sculptra plan, a PDO thread suggestion, or a PRP scalp evaluation. That sheet closes the acquisition-to-conversion gap that kills most Dallas injectable campaigns.
Dallas submarkets and neighborhoods we serve for injectables marketing
The Highland Park–Preston Hollow–University Park–Park Cities corridor is the highest-CPC injectable auction in Texas. Uptown and Turtle Creek carry the young-professional preventative-injectable buyer. Bishop Arts and Lakewood have added boutique injector suites over the past three years. The Frisco–Plano–McKinney corridor carries family-aesthetic, post-baby filler, and PRP demand at more accessible CPCs. Fort Worth twin-city crossover is scoped through the Fort Worth hub. We price the CPC premium correctly per submarket rather than budget to a citywide average.
The compliance stack every Dallas injectables engagement is scoped against
Every campaign, creative, landing page, email sequence, SMS motion, and influencer collaboration is filtered against this stack before publication. The stack is not additive — the tightest rule always governs. Injectables sit under more overlapping oversight than any other cash-pay aesthetic category, and the discipline is what protects the clinic through a five-year growth arc.
Retainer scope for Dallas injectables clinic engagements
Retainers run custom-scoped from $2,500 to $8,000/month. Media spend is pass-through and scoped separately. Angryturtle GBP OS runs in parallel where per-location Google Business Profile density is the acquisition constraint. All pricing is US dollar denominated.
- Single-injector boutique — $2,500 to $4,000/month. SEO on two-to-three injectable product hubs, one GBP, Meta Ads on neuromodulator + filler cosmetic intent, monthly reporting, quarterly Rule 165.5 audit.
- Two-to-three location injectables group — $4,000 to $6,000/month. Full SEO across all six product families + GBP density + Google + Meta + Instagram + TikTok injector-brand + reputation cross-monitoring + injectables membership funnel.
- Multi-location aesthetic platform or PE-backed group — $6,000 to $8,000+/month. Full stack + per-location P&L attribution + CRM integration + YouTube injector-authority publishing + FTC-disclosure influencer program + quarterly compliance re-audits.
Dallas injectables marketing — common questions from practice owners
Which injectables can we actively market in Dallas without FDA or TX Medical Board exposure?
On-label promotion is safe for the FDA-approved indication of each product — Botox and Dysport for glabellar and crow's feet lines, Juvederm Voluma for mid-face volume, Restylane Kysse for lip augmentation, Sculptra for shallow-to-deep facial wrinkles, Kybella for submental fat, PDO threads under their 510(k)-cleared soft-tissue approximation clearance. Off-label uses (masseter Botox, cheek Sculptra biostimulation, hyperdilute Radiesse skin-quality, non-surgical rhinoplasty with filler) are described as visit outcomes, never as FDA indications, per 21 CFR §202.1. The consult conversation carries the clinical detail; the Meta ad and Google Ad describe what the buyer will feel and see.
How do TX Med Board Rule 165.5 and Rule 165.1 apply to filler and thread before/after content?
Rule 165.5 requires signed consent on every face-visible asset, "results not typical" disclosure in the same field of view, no filters or lighting changes between frames, time-stamped follow-ups, and compensation disclosure on any incentivized content. Rule 165.1 prohibits superiority language — "best filler injector in Dallas," "top-rated Sculptra provider" fail. Threads and filler get scrutinized harder than neuromodulators because the visible change is larger, so we run tighter disclosure and cleaner time-stamps on any thread lift, Voluma mid-face, or Sculptra full-face content.
What is the CPQL range for Dallas injectables consultations by product?
Highland Park and Preston Hollow ranges: neuromodulators $50 to $110, HA filler $70 to $150, biostimulators (Sculptra, Radiesse) $90 to $180, PDO threads $85 to $170, PRP facial + PRP hair $65 to $140, Kybella submental $60 to $130, injectables membership enrollment $75 to $160. Uptown and Park Cities run 10 to 15% lower. DFW suburbs run 25 to 40% lower. First-quarter campaigns run 30 to 60% higher while creative and audiences stabilize.
Can we market PRP for facial rejuvenation and hair restoration together in Dallas?
Yes, and they are the two highest-crossover injectables in the Dallas market. PRP facial (microneedling + PRP) and PRP hair (scalp injections for androgenetic alopecia) share buyers frequently — the buyer who books PRP facial is a strong candidate for PRP hair inside twelve months, and vice versa. We run them as parallel funnels with shared retargeting audiences, distinct landing pages, and coordinated Rule 165.5 disclosure on all before/after content. Since PRP is not FDA-approved for either indication, all marketing describes technique and visit outcome, never an FDA endorsement.
How do injectables membership programs work inside the marketing motion?
Membership pricing on injectables — monthly units banked, filler credits accumulated, quarterly biostimulator sessions unlocked — is the strongest LTV lever in Dallas. We scope enrollment landing pages, Alle rewards integration (Allergan / AbbVie ecosystem covers Botox, Juvederm, Kybella, and CoolSculpting), Aspire rewards where Galderma products (Dysport, Restylane, Sculptra) are the primary shelf, retention email + SMS sequences, and the visit-cadence triggers that convert a Botox member into a filler or Sculptra patient. Membership is not a separate service line — it is the retention layer of the injectables marketing motion.
Do you scope Meta ad copy differently for neuromodulators versus fillers versus biostimulators?
Yes. Neuromodulator copy leans on maintenance-ritual and preventative-injectable framing — "how I book my quarterly Botox" — and stays inside Meta Personal Attributes with first-person aspirational language. Filler copy leans on natural-looking projection and single-visit outcome — "the injector-led Voluma mid-face refresh in Preston Hollow" — with category framing, not viewer framing. Biostimulator copy (Sculptra, hyperdilute Radiesse) leans on collagen-building over three-to-six-month timelines — the ad has to educate the buyer on what a biostimulator actually is, because most Dallas buyers still confuse it with a traditional filler. All three stay inside Meta Personal Attributes in first-person, category-framing, injector-led voice.
Scope your Dallas injectables marketing engagement
Book a 30-minute scoping call with a member of the Leadership Team, email Santosh (Dallas HQ) directly, or WhatsApp us — Central Time hours, same day where we can.
Adjacent Dallas and US marketing hubs
Healthcare brands ICG
has worked with.
A representative slice of the 150+ healthcare brands ICG has delivered for across India. Full client list available under NDA during a Brand and Growth Diagnostic.
